[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"autoimmune-cytopenias\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:autoimmune-cytopenias":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":4},"100658127","long-term-follow-up-study-of-gamgertamig-100658127",false,"NCT07847892","Long-Term Follow-Up Study of Gamgertamig","A Multicenter, Long-Term Follow-Up Study in Participants Who Previously Participated in a Gamgertamig (OM336) Parent Clinical Study","Inclusion Criteria:\n\n* Completed the protocol-defined treatment regimen in an eligible parent gamgertamig study.\n* Achieved and continues to demonstrate a clinical response.\n* Able and willing to provide informed consent.\n\nExclusion Criteria:\n\n* Not applicable.","ALL","18 Years","75 Years",{"count":20,"type":21},100,"ESTIMATED","OBSERVATIONAL","This study will follow adults who previously received gamgertamig in another clinical study to evaluate long-term safety and clinical outcomes.",[25],"Autoimmune Cytopenias","NOT_YET_RECRUITING","2026-09-23",{"date":29,"type":30},"2026-09-29","ACTUAL",{"date":32,"type":21},"2026-10",{"date":34,"type":21},"2029-12",{"name":36,"class":37},"Lakefront Biotherapeutics West LLC","INDUSTRY"]